K110233 is an FDA 510(k) clearance for the HAIRMAX LASERCOMB. Classified as Laser, Comb, Hair (product code OAP), Class II - Special Controls.
Submitted by Lexington International, LLC (Washington, US). The FDA issued a Cleared decision on May 27, 2011 after a review of 121 days - within the typical 510(k) review window.
This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 890.5500 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.
View all Lexington International, LLC devices
NCT00981461
Completed
Interventional
Industry-sponsored
Treatment of Androgenetic Alopecia in Females, 9 Beam
A Randomized, Double-Blind Clinical Trial to Evaluate the Safety and Efficacy of the HairMax LaserComb 2009, 9 Beam Model: For the Treatment of Androgenetic Alopecia in Females
| Condition studied |
Androgenetic Alopecia; Hair Loss; Female Pattern Baldness |
| Study design |
Parallel |
| Eligibility |
Female only
· 25 Years+
· Healthy volunteers accepted
|
| Principal investigator |
Michael Jarratt, M.D. |
| Sponsor |
Lexington International, LLC
(industry)
|
Started 2009-10-01
→
Primary completion 2010-10-01
Primary outcome
Changes in Terminal Hair Count Week 16 and 26 Weeks Over Baseline
View full study on ClinicalTrials.gov